References
- a NRCUCoAFfD. Disease NFfDaNTo: Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. Washington, D. C. USA: The National Academies Press; 2011.
- Mentis AA, Pantelidi K, Dardiotis E, et al. Precision Medicine and Global Health: the Good, the Bad, and the Ugly. Front Med (Lausanne). 2018;5:67.
- Kimmelman J, Tannock I. The paradox of precision medicine. Nat Rev Clin Oncol. 2018;15:341–342.
- Kogan JN, Empey P, Kanter J, et al. Delivering on the value proposition of precision medicine: the view from healthcare payers. Am J Manag Care. 2018;24:177–179.
- Peer D. Precision medicine–delivering the goods? Cancer Letters. 2014;352:2–3.
- Mazzarella L. Are we ready for routine precision medicine? Highlights from the Milan Summit on Precision Medicine, Milan, Italy, 8-9 February 2018. Ecancermedicalscience. 2018;12:817.
- Cascorbi I. Significance of Pharmacogenomics in Precision Medicine. Clin Pharmacol Ther. 2018;103:732–735.
- Ji Y, Si Y, McMillin GA, et al. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine. Expert Rev Mol Diagn. 2018;18:1–11.
- Pages F, Mlecnik B, Marliot F, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391:2128–2139.
- Ogino S, Giannakis M. Immunoscore for (colorectal) cancer precision medicine. Lancet. 2018;391:2084–2086.
- Marks KM, West NP, Morris E, et al. Clinicopathological, genomic and immunological factors in colorectal cancer prognosis. Br J Surg. 2018;105:e99–e109.
- Janssens JP, Rotenberg L, Sentis M, et al. Schulz-Wendtland R: caution with microbiopsies of the breast: displaced cancer cells and ballistics. Eur J Cancer Prev. 2006;15:471–473.
- Mariani S, Bertero L, Coppola V, et al. Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices. Expert Rev Mol Diagn. 2018;18:467–475.
- Pritzker KP, Pritzker LB. Bioinformatics advances for clinical biomarker development. Expert Opin Med Diagn. 2012;6:39–48.
- Pritzker KPH. Cancer biomarkers: easier said than done. Clin Chem. 2002;48:1147–1150.
- Aronson SJ, Rehm HL. Building the foundation for genomics in precision medicine. Nature. 2015;526:336–342.
- Stausberg J, Kuklik N, Jockel KH. Opportunities and Pitfalls in the Definition of Data Validity. Stud Health Technol Inform. 2018;247:566–570.
- Awuah B, Martin IK, Takyi V, et al. Implementation of a percutaneous core needle biopsy training program: results from the University of Michigan-Komfo Anokye Teaching Hospital breast cancer research partnership. Ann Surg Oncol. 2011;18:957–960.
- Khoury T. Delay to Formalin Fixation (Cold Ischemia Time) Effect on Breast Cancer Molecules. Am J Clin Pathol. 2018;149:275–292.
- Wallin A, Kapaki E, Boban M, et al. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease – a consensus report. BMC Neurol. 2017;17:102.
- Tsui FW, Tsui HW, Las Heras F, et al. Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis. Ann Rheum Dis. 2014;73:1873–1879.
- Parlato M, Charbit-Henrion F, Pan J, et al. Cerf-Bensussan N: human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis. EMBO Mol Med. 2018;10:e8483.
- Bilski J, Mazur-Bialy A, Wojcik D, et al. The Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract. Mediators Inflamm. 2017;2017:9074601.
- Brunoni AR, Padberg F, Vieira ELM, et al. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86:211–217.
- Rodriguez H, Pennington SR. Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing. Cell. 2018;173:535–539.
- McKenna MT, Weis JA, Brock A, et al. Precision Medicine with Imprecise Therapy: computational Modeling for Chemotherapy in Breast Cancer. Transl Oncol. 2018;11:732–742.